Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

BACKGROUND: Thiazolidinediones (TZDs), rosiglitazone (RGZ) and pioglitazone (PGZ) are widely used as hypoglycemic drugs in patients with type 2 diabetes mellitus. The aim of our study was to investigate the profile of adverse drug reactions (ADRs) related to TZDs and to investigate potential risk fa...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Berthet, Stephanie, Olivier, Pascale, Montastruc, Jean-Louis, Lapeyre-Mestre, Maryse
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3119167/
https://ncbi.nlm.nih.gov/pubmed/21609444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-11-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky